newsfilter
← Latest News
GlobeNewswire·

Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split

HOUSTON, June 12, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for